China is reportedly considering using foreign-produced vaccines as booster injections or booster for people who have been fully injected with Chinese vaccines, such as Sinovac and Sinopharm.
According to Caixin, China’s respected financial magazine, China’s drug regulator has completed an expert panel review of vaccines booster jointly developed by Shanghai Fosun Pharmaceutical (Fosun Pharma) and German company BioNTech. The booster injection, Fosun-BioNTech COVID-19, is now under administrative review.
The report comes days after Thailand and Indonesia announced that they would switch from Chinese-made doses to Western-made vaccines.
Thailand, which has used Sinovac’s vaccine, is now seeing an increase in cases and deaths. In Indonesia, where cases are soaring, less than 7% of its population of 271 million have been vaccinated, according to Johns Hopkins. Indonesia has placed one of the world’s largest orders for the Sinovac vaccine, purchasing 125 million doses.
Indonesia and Thailand will stop using Sinovac’s vaccine once supplies run out, a step Malaysia will also take, according to The Diplomat. The Philippines and Chile are researching the possible use of Fosun-BioNTech boosters and vaccines that are not made in China. [lt/ft]